XML 38 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION PLANS
12 Months Ended
Aug. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION PLANS
NOTE 15. STOCK-BASED COMPENSATION PLANS

The Company's stock-based compensation plans provide for the issuance of incentive and nonqualified stock options, restricted stock and units, stock appreciation rights and performance-based awards. The Compensation Committee of CMC's Board of Directors (the "Compensation Committee") approves all awards that are granted under the Company's stock-based compensation plans. Stock-based compensation expense for the years ended August 31, 2017, 2016 and 2015 of $30.3 million, $26.4 million and $23.5 million, respectively, is mainly included in selling, general and administrative expenses on the Company's consolidated statements of earnings. As of August 31, 2017, total unrecognized compensation cost related to unvested stock-based compensation arrangements was $19.3 million, which is expected to be recognized over a weighted-average period of three years, except for certain restricted stock units granted during fiscal 2014, which are expected to vest over a weighted-average period of four years.
The following table summarizes the total awards granted:
 
 
Restricted Stock
Awards/Units
 
Performance
Awards
2017 Grants
 
1,303,976

 
576,286

2016 Grants
 
1,137,000

 
540,295

2015 Grants
 
987,574

 
462,496



As of August 31, 2017, CMC had 11,144,004 shares available for future grants.

Restricted Stock Units

Restricted stock units issued under the Company's stock-based compensation plans provide that units awarded may not be sold, transferred, pledged or assigned until service-based restrictions lapse. The restricted stock units granted to U.S. employees generally vest and are converted to CMC common stock in three equal installments on each of the first three anniversaries of the date of grant. The restricted stock units granted to non-U.S. employees generally vest and are settled in cash in three equal installments on each of the first three anniversaries of the date of grant. Generally, upon termination of employment, restricted stock units that have not vested are forfeited. Upon death, disability or qualifying retirement, a pro-rata portion of the unvested restricted stock awarded will vest and become payable.

Certain restricted stock units granted during fiscal 2014 will vest and either convert to CMC common stock or settle in cash after a specified service period; 25% vest two years from the date of grant; 25% vest three years from the date of grant; and the remaining 50% vest four years from the date of grant.

The estimated fair value of the stock-settled restricted stock units is based on the closing price of CMC common stock on the date of grant, discounted for the expected dividend yield through the vesting period. Compensation cost related to the stock-settled restricted stock units is recognized ratably over the service period and is included in equity on the Company's consolidated balance sheets. During the first quarter of fiscal 2017, certain restricted stock units and performance stock units (the "modified stock units") that were previously accounted for under the equity method were modified to allow optionality related to the net share settlement feature, which resulted in accounting for these awards under the liability method. The fair value of the cash-settled restricted stock units as well as the modified stock units is remeasured each reporting period and is recognized ratably over the service period. The liability related to the cash-settled restricted stock units and modified stock units is included in accrued expenses and other payables on the Company's consolidated balance sheets. For the year ended August 31, 2017, the Company recorded expense of $2.8 million as a result of the modification and the impact of the change in stock value on liability-treated awards, compared to immaterial mark-to-market adjustments for the year ended August 31, 2016.

Performance Stock Units

Performance stock units issued under the Company's stock-based compensation plans provide that units awarded may not be sold, transferred, pledged or assigned until service-based restrictions lapse and any performance objectives have been attained as established by the Compensation Committee. Recipients of these awards generally must be actively employed by and providing services to the Company on the last day of the performance period in order to receive an award payout. Upon death, disability or qualifying retirement, a pro-rata portion of the performance stock units will vest and become payable at the end of the performance period.

Compensation cost for performance stock units is accrued based on the probable outcome of specified performance conditions, net of estimated forfeitures. The Company accrues compensation cost if it is probable that the performance conditions will be met. The Company reassesses the probability of meeting the specified performance conditions at the end of each reporting period and adjusts compensation cost, as necessary, based on the probability of achieving the performance conditions. If the performance conditions are not met at the end of the performance period, the Company reverses the related compensation cost.

Performance targets established by the Compensation Committee for performance stock units awarded in fiscal years 2017, 2016 and 2015 are weighted 75% based on the Company's cumulative EBITDA targets and positive return on invested capital for the fiscal year in which the awards were granted and the succeeding two fiscal years, as approved by CMC's Board of Directors in the respective year's business plan, and 25% based on a three year relative total stockholder return metric. Performance stock units awarded to U.S. participants will be settled in CMC common stock. Award payouts range from a threshold of 50% to a maximum of 200% for each portion of the target awards. The performance stock units awarded in fiscal years 2017 and 2016 associated with the cumulative EBITDA targets have been classified as liability awards since the final EBITDA target will not be set until the third year of the performance period. Consequently, these awards are included in accrued expenses and other payables on the Company's consolidated balance sheets. The fair value of these performance stock units is remeasured each reporting period and is recognized ratably over the service period. The performance stock units associated with the total stockholder return metric were valued at fair value on the date of grant using the Monte Carlo pricing model and are included in equity on the Company's consolidated balance sheets.

Performance stock units awarded to non-U.S. participants in fiscal 2017, 2016 and 2015 will be settled in cash. The fair value of the performance stock units is remeasured each reporting period and is recognized ratably over the service period. The liability related to these awards is included in accrued expenses and other payables on the Company's consolidated balance sheets.

Information for restricted stock units and performance stock units, excluding those expected to settle in cash, is as follows:
 
Number
 
Weighted Average
Grant-Date
Fair Value
Outstanding as of September 1, 2014
2,080,580

 
$
15.37

Granted
1,468,696

 
15.79

Vested
(712,279
)
 
14.33

Forfeited
(103,663
)
 
15.51

Outstanding as of August 31, 2015
2,733,334

 
15.86

Granted
1,612,772

 
15.83

Vested
(1,471,436
)
 
14.47

Forfeited
(174,440
)
 
17.60

Outstanding as of August 31, 2016
2,700,230

 
16.49

Granted
1,462,442

 
16.17

Vested
(1,385,753
)
 
17.62

Forfeited
(323,339
)
 
16.58

Outstanding as of August 31, 2017
2,453,580

 
$
15.65



The total fair value of shares vested during fiscal years 2017, 2016 and 2015 was $24.4 million, $21.3 million and $10.2 million, respectively.

The Company granted 914,545 and 464,782 equivalent shares of restricted stock units and performance stock units accounted for as liability awards during the years ended August 31, 2017 and 2016, respectively. As of August 31, 2017, the Company had 1,752,492 equivalent shares of awards outstanding and expects 1,671,441 equivalent shares to vest.

Stock Appreciation Rights

Stock appreciation rights are awarded to certain employees with an exercise price equal to the market value of CMC common stock on the date of grant. No stock appreciation rights were granted during the years ended August 31, 2017, 2016, and 2015.

Combined activity for the Company's stock appreciation rights, excluding the cash component, is as follows:
 
Number
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Life
(Years)
 
Aggregate
Intrinsic Value
Outstanding as of September 1, 2014
1,437,031

 
$
19.85

 
 
 
 
Exercised
(142,604
)
 
11.80

 
 
 
 
Forfeited/Expired
(452,210
)
 
35.10

 
 
 
 
Outstanding as of August 31, 2015
842,217

 
$
13.04

 
2.7
 
$
2,243,765

Exercised
(418,378
)
 
12.10

 
 
 
 
Forfeited/Expired
(64,845
)
 
11.60

 
 
 
 
Outstanding as of August 31, 2016
358,994

 
$
14.39

 
1.7
 
$
405,864

Exercised
(235,687
)
 
14.72

 

 
 
Forfeited/Expired
(14,000
)
 
14.05

 

 
 
Outstanding as of August 31, 2017
109,307

 
$
13.72

 
1.3
 
$
564,826

Exercisable at August 31, 2017
109,307

 
$
13.72

 
1.3
 
$
564,826

Remaining unvested stock appreciation rights expected to vest

 
$

 
 
 
 


The total intrinsic value of stock appreciation rights exercised during fiscal 2017 and 2016 was $1.4 million and $2.2 million, respectively. The total intrinsic value of stock appreciation rights exercised during fiscal 2015 was not material.

Information related to stock appreciation rights as of August 31, 2017 is summarized below:
 
 
Stock Appreciation Rights Outstanding and Exercisable
Range of Exercise Prices
 
Number Outstanding and Exercisable
 
Weighted Average Remaining Contractual Life (In Years)
 
Weighted Average Exercise Price
$11.60
-
14.12
 
81,307

 
1.6
 
$
12.65

$16.83
-
16.83
 
28,000

 
0.4
 
$
16.83

 
 

 
109,307

 
1.3
 
$
13.72



As of August 31, 2017, the Company had 6,367 equivalent shares of cash-settled stock appreciation rights outstanding and expects 6,048 equivalent shares of cash-settled stock appreciation rights to vest.
Stock Purchase Plan

Almost all U.S. resident employees with one year of service at the beginning of each calendar year may participate in the Company's employee stock purchase plan. Each eligible employee may purchase up to 400 shares annually. The Board of Directors established the purchase discount of 15% based on market prices on specified dates for the years ended August 31, 2017, 2016 and 2015. Yearly activity of the stock purchase plan is as follows:
 
 
2017
 
2016
 
2015
Shares subscribed
 
173,420

 
212,370

 
198,710

Price per share
 
$
18.99

 
$
12.03

 
$
13.73

Shares purchased
 
166,220

 
156,860

 
172,170

Price per share
 
$
12.04

 
$
13.71

 
$
16.96

Shares available for future issuance
 
3,517,604